Genmab — Juli 2018
-
Grafen ser flot ud. Siden 2. juli har aktien steget stille og roligt med 170 kr.
-
small new Phase 1 Study of Daratumumab When Given in Combination With Bortezomib, Dexamethasone, Doxil, and Lenalidomide in Patients With Plasma Cell Leukemia - https://clinicaltrials.gov/ct2/show/NCT03591744?term=daratumumab+OR+ofatumumab+OR+tisotumab&lupd_s=07%2F18%2F2018&rank=3
-
-
this Atezolizumab sstudy updated again https://clinicaltrials.gov/ct2/history/NCT02431208?A=39&B=40&C=merged
-
Trenden er vores ven......igen.

-
God weekend til alle. Jeg går på sommerferie i aften til søndag morgen, hvor jeg som vanligt har vagten i familiens butik.

-
Grunden til at vi fik et positivt luk var, at Danske løb tør. De havde kun 1000 aktier tilbage i auktionen, efter at ha
ve holdt kursen nede hele dagen. Danske og ABG har dagen igennem netto solgt flere, end de anonyme har har netto købt, og de har næsten været ene om at købe. så - bibob (10.28) der var nogen, der ville sælge.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
